Loading...
Gevo, Inc.
GEVO•NASDAQ
Basic Materials
Chemicals - Specialty
$1.47
$-0.03(-2.00%)
Gevo, Inc. (GEVO) Financial Performance & Income Statement Overview
Review Gevo, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-1.66%
↓ 1.66%
Operating Income Growth
-10.98%
↓ 10.98%
Net Income Growth
-18.76%
↓ 18.76%
Operating Cash Flow Growth
-6.82%
↓ 6.82%
Operating Margin
-208.93%
↓ 208.93%
Gross Margin
26.58%
↑ 26.58%
Net Profit Margin
-193.87%
↓ 193.87%
ROE
-16.41%
↓ 16.41%
ROIC
-14.01%
↓ 14.01%
Gevo, Inc. (GEVO) Income Statement & Financial Overview
Review Gevo, Inc.'s (GEVO) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $5.70M | $1.97M | $5.26M | $3.99M |
| Cost of Revenue | $3.45M | $2.54M | $8.40M | $8.11M |
| Gross Profit | $2.25M | -$579000.00 | -$3.14M | -$4.12M |
| Gross Profit Ratio | $0.40 | -$0.29 | -$0.60 | -$1.03 |
| R&D Expenses | -$208000.00 | $1.11M | $1.64M | $1.55M |
| SG&A Expenses | $10.46M | $11.68M | $19.25M | $17.47M |
| Operating Expenses | $21.90M | $23.43M | $20.89M | $19.02M |
| Total Costs & Expenses | $25.35M | $25.97M | $29.29M | $27.13M |
| Interest Income | $3.16M | $3.84M | $4.14M | $4.59M |
| Interest Expense | $1.12M | $1.11M | $1.11M | $542000.00 |
| Depreciation & Amortization | $6.08M | $3.49M | $4.28M | $4.45M |
| EBITDA | -$10.41M | -$16.55M | -$19.75M | -$13.88M |
| EBITDA Ratio | -$1.83 | -$8.42 | -$3.76 | -$3.48 |
| Operating Income | -$19.65M | -$24.008M | -$24.03M | -$23.14M |
| Operating Income Ratio | -$3.45 | -$12.22 | -$4.57 | -$5.80 |
| Other Income/Expenses (Net) | $2.04M | $2.85M | $3.03M | $4.27M |
| Income Before Tax | -$17.61M | -$21.16M | -$21.002M | -$18.88M |
| Income Before Tax Ratio | -$3.09 | -$10.77 | -$3.99 | -$4.73 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $4.41M |
| Net Income | -$17.61M | -$21.16M | -$21.002M | -$18.88M |
| Net Income Ratio | -$3.09 | -$10.77 | -$3.99 | -$4.73 |
| EPS | -$0.07 | -$0.09 | -$0.09 | -$0.08 |
| Diluted EPS | -$0.07 | -$0.09 | -$0.09 | -$0.08 |
| Weighted Avg Shares Outstanding | $239.18M | $239.45M | $239.01M | $240.84M |
| Weighted Avg Shares Outstanding (Diluted) | $239.18M | $239.45M | $239.01M | $240.84M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan